Gut microbiota and liver disease

Area of Science:

• Microbiology
• Gastroenterology
• Hepatology

Background:

• The human gastrointestinal tract hosts a vast number of microbes, collectively known as gut microbiota.
• Historically, studying these microbes was challenging, but recent technological advancements have improved our understanding of their roles in health and disease.
• The gut microbiota is increasingly recognized for its indispensable role in maintaining host homeostasis.

Purpose of the Study:

• To review current knowledge on normal gut microbiota.
• To summarize laboratory techniques and animal models used for studying gut microbiota.
• To explore the role of gut microbiota perturbations in common hepatic disorders.

Main Methods:

• Literature review of recent scientific publications.
• Summary of established and emerging laboratory techniques for microbiota analysis.
• Overview of animal models utilized in gut microbiota research.

Main Results:

• Gut microbiota alterations are implicated in the pathogenesis and progression of various gastrointestinal and hepatic diseases.
• Specific liver conditions discussed include non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcoholic liver disease (ALD), and liver cirrhosis.
• Perturbations in gut flora present therapeutic and preventative strategies for liver disorders.

Conclusions:

• The gut microbiota is a significant factor in liver disease development and progression.
• Targeting the gut microbiota offers potential therapeutic avenues for managing hepatic disorders.
• Further research into gut microbiota composition and function is crucial for advancing liver disease treatment.